Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
PCRX
#2109
Pacira BioSciences, Inc. Common Stock
21.910
0
-5.88%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
-5.88%
Variazione Mensile
+10.54%
Variazione di 6 mesi
+0.37%
Variazione Annuale
+0.37%
Chiusura Precedente
23.280
0
Open
21.910
0
Bid
Ask
Low
21.910
0
High
21.910
0
Volume
171
Mercati
Mercato Azionario Statunitense
Salute
PCRX
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
43.86 M
44.85 M
45.95 M
46.5 M
46.28 M
40.49 M
—
Valuation ratios
Enterprise value
2.52 B
2.11 B
1.68 B
1.33 B
595.07 M
889.33 M
3.49 B
Price to earnings ratio
17.97
65.4
114.29
35.96
-8.76
161.75
194.53
Price to sales ratio
6.08
5.07
2.71
2.46
119.65
—
—
Price to cash flow ratio
33.93
21.84
12.45
10.76
4.6
7.67
30.88
Price to book ratio
4.22
3.76
2.33
1.91
1.12
1.68
2.79
Enterprise value to EBITDA ratio
8.64
6.03
4.07
2.8
-1.67
—
—
Profitability ratios
Return on assets %
0.11
0.02
0.01
0.03
-0.06
0.01
-0.01
Return on equity %
0.23
0.06
0.02
0.05
-0.13
0.01
-0.02
Return on invested capital %
-155.42
22.44
13.41
19.05
-11.09
3.31
0.87
Gross margin %
72.69
74.1
70.11
72.64
-2 240.4
79.39
317.56
Operating margin %
10.79
16.61
9
12.99
-1 007.57
2.64
10.6
EBITDA margin %
68.05
64.67
61.97
70.6
-4 903.28
13.36
23.17
Net margin %
33.87
7.75
2.39
6.22
-1 367.21
0.97
-6.26
Liquidity ratios
Quick ratio
2.32
1.47
2.72
4.17
2
3.28
10.96
Current ratio
2.57
1.66
3.37
5.24
2.4
4.54
14.6
Inventory turnover
—
—
—
—
—
0.01
—
Asset turnover
0.41
0.32
0.36
0.41
0
0.52
0.5
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.25
0.33
0.39
0.33
0.25
0.29
1.07
Long term debt to total equity ratio
0.51
0.92
0.85
0.59
0.49
0.54
2.03
Per share metrics
Operating cash flow per share
1.76
2.76
3.12
2.98
4.1
3.37
3.32
EBIT per share
6.24
7.05
6.91
7.71
-9.42
0.13
-1.24
EBITDA per share
6.69
7.68
8.88
9.17
-7.72
2.15
0.75
Total debt per share
—
—
—
—
—
—
—
Cash per share
11.94
14.39
6.2
5.36
10.48
5.29
31.01
Net current asset value per share
14.92
18.98
10.71
9.81
16.11
12.17
57.06
Tangible book value per share
9.7
-0.85
1.53
4.3
7.62
6.77
28.08
Working capital per share
9.12
7.56
7.53
7.94
9.41
9.49
38.45
Book value per share
14.19
16.01
16.65
16.74
16.83
15.39
64.98
Notizie
Pacira BioSciences, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:PCRX) 2026-02-27
Pacira BioSciences Q4 Earnings and Revenues Miss Estimates, Stock Down
Pacira PharmaceuticalsQ4每股收益及营收逊于预期
Pacira即将公布财报,EXPAREL面临仿制药威胁
Pacira BioSciences: Mispriced On Generic Risks That Are Years Away (NASDAQ:PCRX)
Pacira BioSciences高级副总裁Lauren Riker出售价值8.324万美元股票
Pacira BioSciences SVP Lauren Riker sells $83k in stock
Pacira BioSciences高管Williams出售价值26.9万美元股票
Pacira BioSciences officer Williams sells $269k in shares
5 Drug/Biotech Stocks Likely to Outperform Q4 Earnings Estimates
Pacira BioSciences appoints Samit Hirawat to board of directors
Pacira (PCRX) is an Incredible Growth Stock: 3 Reasons Why